Non-primate lentiviral vectors

Current Opinion in Molecular Therapeutics

Volumn 5, Issue 5, 2003, Pages 529-540

  Poeschla, Eric M ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

EIAV; FIV; Gene therapy; Lentivirus; Vector

Indexed keywords

ARGIPRESSIN; BETA GALACTOSIDASE; BETA GLUCURONIDASE; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; LENTIVIRUS VECTOR; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

CAT; DRUG EFFICACY; DRUG SAFETY; GENETIC ENGINEERING; GLAUCOMA; HEMOPHILIA A; HORSE; HUMAN; LIFE CYCLE; MEDICAL RESEARCH; MUCOPOLYSACCHARIDOSIS TYPE 7; NEUROGENIC DIABETES INSIPIDUS; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; RETINA DISEASE; REVIEW; SPECIES DIFFERENCE; TISSUE CULTURE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIROLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; DIGESTIVE SYSTEM DISEASES; EYE DISEASES; GENE THERAPY; GENETIC VECTORS; HUMANS; LENTIVIRUS; NERVOUS SYSTEM DISEASES; RESPIRATORY TRACT DISEASES;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUINE LENTIVIRUSES; EQUUS CABALLUS; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; LENTIVIRUS; PRIMATES;

EID: 0142185264     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Desrosiers RC: Nonhuman lentiviruses. In: Fields Virology. Knipe DM, Howley PM (Eds), Lippincott Williams and Wilkins, Philadelphia, PA, USA (2001):2095-2121.
2. Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR: An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 339(6223):389-392.
3. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM et al: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 397(6718):436-441.
4. Letvin NL, Daniel MD, Sehgal PK, Desrosiers RC, Hunt RD, Waldron LM, MacKey JJ, Schmidt DK, Chalifoux LV, King NW: Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science (1985) 230(4721):71-73.
5. Rey-Cuille MA, Berthier JL, Bomsel-Demontoy MC, Chaduc Y, Montagnier L, Hovanessian AG, Chakrabarti LA: Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol (1998) 72(5):3872-3886.
6. Pedersen NC: The feline immunodeficiency virus. In: The Retroviridae. Levy JA (Ed), Plenum Press, New York, NY, USA (1993):181-228.
7. Elder JH, Phillips TR: Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. Adv Virus Res (1995) 45:225-247.
8. Campbell RS, Robinson WF: The comparative pathology of the lentiviruses. J Comp Pathol (1998) 119(4):333-395.
9. Clements JE, Zink MC, Narayan O, Gabuzda DH: Lentivirus infection of macrophages. Immunol Ser (1994) 60:589-600.
10. Georgsson G: Neuropathologic aspects of lentiviral infections. Ann NY Acad Sci (1994) 724:50-67.
11. Elder JH, Dean GA, Hoover EA, Hoxie JA, Malim MH, Mathes L, Neil JC, North TW, Sparger E, Tompkins MB, Tompkins WA et al: Lessons from the cat: Feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 14(9):797-801.
12. Gonda MA, Luther DG, Fong SE, Tobin GJ: Bovine immunodeficiency virus: Molecular biology and virus-host interactions. Virus Res (1994) 32(2):155-181.
13. Parolin C, Dorfman T, Palu G, Gottlinger H, Sodroski J: Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J Virol (1994) 68(6):3888-3895.
14. Naldini L, Bloemer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 272(5259):263-267.
15. Naldini L, Verma IM: Lentiviral vectors. Adv Virus Res (2000) 55:599-609.
16. Vigna E, Naldini L: Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med (2000) 2(5):308-316.
17. Vallée H, Carré H: Sur la nature infectieuse de l'anaemie du cheval. CR Hebd Seances Acad Sci (1904) 139:331-333.
18. Sigurdsson B, Palsson PA, Grimsson H: Visna: A demyelinating transmissbile disease of sheep. J Neuropathol Exp Neurol (1957) 16:389-403.
19. Haase AT: The slow infection caused by visna virus. Curr Top Microbiol Immunol (1975) 72:101-156.
20. Haase AT, Varmus HE: Demonstration of a DNA provirus in the lytic growth of visna virus. Nat New Biol (1973) 245(147):237-239.
21. Haase AT, Stowring L, Narayan P, Griffin D, Price D: Slow persistent infection caused by visna virus: Role of host restriction. Science (1977) 195(4274):175-177.
22. Brahic M, Stowring L, Ventura P, Haase AT: Gene expression in visna virus infection in sheep. Nature (1981) 292(5820):240-242.
23. Kobayashi K: Studies on the cultivation of equine infectious anemia virus in vitro. I. Serial cultivation of the virus in the cuture of various horse tissues. Virus (1961) 11:177-189.
24. Sigurdsson B, Thormar H, Palsson PA: Cultivation of visna virus in tissue culture. Arch Gesamte Virusforsch (1960) 10:368.
25. Pedersen NC, Ho EW, Brown ML, Yamamoto JK: Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 235(4790):790-793.
26. Gonda MA, Braun MJ, Carter SG, Kost TA, Bess JW Jr, Arthur LO, Van der Maaten MJ: Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus. Nature (1987) 330(6146):388-391.
27. Chadwick BJ, Coelen RJ, Sammels LM, Kertayadnya G, Wilcox GE: Genomic sequence analysis identifies Jembrana disease virus as a new bovine lentivirus. J Gen Virol (1995) 76(1):189-192.
28. Lewis PF, Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol (1994) 68(1):510-516.
29. Poeschla EM, Wong-Staal F, Looney DJ: Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med (1998) 4(3):354-357.
30. Hope T: Improving the post-transcriptional aspects of lentiviral vectors. Curr Top Microbiol Immunol (2002) 261:179-189.
31. Olsen JC: Gene transfer vectors derived from equine infectious anemia virus. Gene Ther (1998) 5(11):1481-1487.
32. Mitrophanous K, Yoon S, Rohll J, Patil D, Wilkes F, Kim V, Kingsman S, Kingsman A, Mazarakis N: Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther (1999) 6(11):1808-1818.
33. Berkowitz R, Ilves H, Lin WY, Eckert K, Coward A, Tamaki S, Veres G, Plavec I: Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus. J Virol (2001) 75(7):3371-3382.
34. Metharom P, Takyar S, Xia HH, Ellem KA, Macmillan J, Shepherd RW, Wilcox GE, Wei MQ: Novel bovine lentiviral vectors based on Jembrana disease virus. J Gene Med (2000) 2(3):176-185.
35. Berkowitz RD, Ilves H, Plavec I, Veres G: Gene transfer systems derived from visna virus: Analysis of virus production and infectivity. Virology (2001) 279(1):116-129.
36. Mselli-Lakhal L, Favier C, Da Silva Teixeira MF, Chettab K, Legras C, Ronfort C, Verdier G, Mornex JF, Chebloune Y: Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors. Arch Virol (1998) 143(4):681-695.
37. Molina RP, Matukonis M, Paszkiet B, Zhang J, Kaleko M, Luo T: Mapping of the bovine immunodeficiency virus packaging signal and RRE and incorporation into a minimal gene transfer vector. Virology (2002) 304(1):10-23.
38. Takahashi K, Luo T, Saishin Y, Sung J, Hackett S, Brazzell RK, Kaleko M, Campochiaro PA: Sustained transduction of ocular cells with a bovine immunodeficiency viral vector. Hum Gene Ther (2002) 13(11):1305-1316.
39. Matukonis M, Li M, Molina RP, Paszkiet B, Kaleko M, Luo T: Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems. Hum Gene Ther (2002) 13(11):1293-1303.
40. Metharom P, Takyar S, Xia HQ, Ellem KA, Wilcox GE, Wei MQ: Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle. Vet Microbiol (2001) 80(1):9-22.
41. Chadwick BJ, Coelen RJ, Wilcox GE, Sammels LM, Kertayadnya G: Nucleotide sequence analysis of Jembrana disease virus: A bovine lentivirus associated with an acute disease syndrome. J Gen Virol (1995) 76(7):1637-1650.
42. Wilcox GE, Kertayadnya G, Hartaningsih N, Dharma DM, Soeharsono S, Robertson T: Evidence for a viral aetiology of Jembrana disease in Bali cattle. Vet Microbiol (1992) 33(1-4):367-374.
43. Kertayadnya G, Wilcox GE, Soeharsono S, Hartaningsih N, Coelen RJ, Cook RD, Collins ME, Brownlie J: Characteristics of a retrovirus associated with Jembrana disease in Bali cattle. J Gen Virol (1993) 74(9):1765-1778.
44. Wilcox GE, Chadwick BJ, Kertayadnya G: Recent advances in the understanding of Jembrana disease. Vet Microbiol (1995) 46(1-3): 249-255.
45. Takahashi K, Saishin Y, Silva RL, Oshima Y, Oshima S, Melia M, Paszkiet B, Zerby D, Kadan MJ, Liau G, Kaleko M et al: Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J (2003) 17(8):896-898.
46. Soeharsono S, Wilcox GE, Putra AA, Hartaningsih N, Sulistyana K, Tenaya M: The transmission of Jembrana disease, a lentivirus disease of Bos javanicus cattle. Epidemiol Infect (1995) 115(2):367-374.
47. Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL, Carter EE, Barber RD, Baban DF, Kingsman SM, Kingsman AJ et al: Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet (2001) 10(19):2109-2121.
48. Azzouz M, Martin-Rendon E, Barber RD, Mitrophanous KA, Carter EE, Rohll JB, Kingsman SM, Kingsman AJ, Mazarakis ND: Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease. J Neurosci (2002) 22(23):10302-10312.
49. Martin-Rendon E, White LJ, Olsen A, Mitrophanous KA, Mazarakis ND: New methods to titrate EIAV-based lentiviral vectors. Mol Ther (2002) 5(5 Pt 1):566-570.
50. Bienemann AS, Martin-Rendon E, Cosgrave AS, Glover CP, Wong LF, Kingsman SM, Mitrophanous KA, Mazarakis ND, Uney JB: Long-term replacement of a mutated nonfunctional CNS gene: Reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin. Mol Ther (2003) 7(5):588-596.
51. Yamada K, Olsen JC, Patel M, Rao KW, Walsh CE: Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector. Mol Ther (2001) 3(4):485-490.
52. Olsen JC: EIAV, CAEV and other lentivirus vector systems. Somat Cell Mol Genet (2001) 26(1-6):131-145.
53. Rohll JB, Mitrophanous KA, Martin-Rendon E, Ellard FM, Radcliffe PA, Mazarakis ND, Kingsman SM: Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors. Methods Enzymol (2002) 346:466-500.
54. Belshan M, Harris ME, Shoemaker AE, Hope TJ, Carpenter S: Biological characterization of Rev variation in equine infectious anemia virus. J Virol (1998) 72(5):4421-4426.
55. Johnston JC, Gasmi M, Lim LE, Elder JH, Yee JK, Jolly DJ, Campbell KP, Davidson BL, Sauter SL: Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 73(6):4991-5000.
56. Curran MA, Kaiser SM, Achacoso PL, Nolan GP: Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther (2000) 1(1):31-38.
57. Song JJ, Lee B, Chang JW, Kim JH, Kwon YK, Lee H: Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer. Virus Res (2003) 93(1):25-30.
58. Loewen N, Fautsch MP, Peretz M, Bahler CK, Cameron JD, Johnson DH, Poeschla EM: Genetic modification of human trabecular meshwork with lentiviral vectors. Hum Gene Ther(2001) 12(17):2109-2119.
59. Loewen N, Bahler C, Teo WL, Whitwam T, Peretz M, Xu R, Fautsch MP, Johnson DH, Poeschla EM: Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest Ophthalmol Vis Sci (2002) 43(12):3686-3690.
60. Loewen N, Leske D, Chen Y, Teo W, Saenz D, Peretz M, Holmes J, Poeschla EM: Comparison of wild type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J Gene Med (2003): in press.
61. Wang G, Slepushkin V, Zabner J, Keshavjee S, Johnston JC, Sauter SL, Jolly DJ, Dubensky TW Jr, Davidson BL, McCray PB Jr: Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest (1999) 104(11):R55-R62.
62. Stein CS, Kang Y, Sauter SL, Townsend K, Staber P, Derksen TA, Martins I, Qian J, Davidson BL, McCray PB Jr: In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol Ther (2001) 3(6):850-856.
63. Brooks AI, Stein CS, Hughes SM, Heth J, McCray PM Jr, Sauter SL, Johnston JC, Cory-Slechta DA, Federoff HJ, Davidson BL: Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci USA (2002) 99(9):6216-6221.
64. Derksen TA, Sauter SL, Davidson BL: Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection. J Gene Med (2002) 4(5):463-469.
65. Lotery AJ, Derksen TA, Russell SR, Mullins RF, Sauter S, Affatigato LM, Stone EM, Davidson BL: Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors. Hum Gene Ther (2002) 13(6):689-696.
66. Kang Y, Stein CS, Heth JA, Sinn PL, Penisten AK, Staber PD, Ratliff KL, Shen H, Barker CK, Martins I, Sharkey CM et al: In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River virus glycoproteins. J Virol (2002) 76(18):9378-9388.
67. Stein CS, Davidson BL: Gene transfer to the brain using feline immunodeficiency virus-based lentivirus vectors. Methods Enzymol (2002) 346:433-454.
68. Curran MA, Nolan GP: Recombinant feline immunodeficiency virus vectors. Preparation and use. Methods Mol Med (2002) 69:335-350.
69. Curran MA, Ochoa MS, Molano RD, Pileggi A, Inverardi L, Kenyon NS, Nolan GP, Ricordi C, Fenjves ES: Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors. Transplantation (2002) 74(3):299-306.
70. Curran MA, Nolan GP: Nonprimate lentiviral vectors. Curr Top Microbiol Immunol (2002) 261:75-105.
71. Alisky JM, Hughes SM, Sauter SL, Jolly D, Dubensky TW Jr, Staber PD, Chiorini JA, Davidson BL: Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport (2000) 11(12):2669-2673.
72. Price MA, Case SS, Carbonaro DA, Yu XJ, Petersen D, Sabo KM, Curran MA, Engel BC, Margarian H, Abkowitz JL, Nolan GP et al: Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol Ther (2002) 6(5):645-652.
73. Haskell RE, Hughes SM, Chiorini JA, Alisky JM, Davidson BL: Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system. Gene Ther (2003) 10(1):34-42.
74. Hughes SM, Moussavi-Harami F, Sauter SL, Davidson BL: Viral-mediated gene transfer to mouse primary neural progenitor cells. Mol Ther (2002) 5(1):16-24.
75. Loewen N, Barraza R, Whitwam T, Saenz D, Kemler I, Poeschla E: FIV Vectors. In: Lentivirus Gene Engineering Protocols. Federico M (Ed), Humana Press, New York, NY, USA (2003):251-271.
76. Sinn PL, Hickey MA, Staber PD, Dylla DE, Jeffers SA, Davidson BL, Sanders DA, McCray PB Jr: Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor α. J Virol (2003) 77(10):5902-5910.
77. Saenz DT, Poeschla EM: FIV: From lentivirus to lentivector. Gene Ther(2003): in press.
78. Poeschla EM, Looney DJ: CXCR4 is required by a nonprimate lentivirus: Heterologous expression of feline immunodeficiency virus in human, rodent and feline cells. J Virol (1998) 72(8):6858-6866.
79. Sauter SL, Gasmi M: FIV vector systems. Somat Cell Mol Genet (2001) 26(1-6):99-129.
80. Kemler I, Barraza R, Poeschla EM: Mapping the encapsidation determinants of feline immunodeficiency virus. J Virol (2002) 76(23):11889-11903.
81. Browning MT, Mustafa F, Schmidt RD, Lew KA, Rizvi TA: Delineation of sequences important for efficient packaging of feline immunodeficiency virus RNA. J Gen Virol (2003) 84(3):621-627.
82. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P: HIV-1 genome nuclear import is mediated by a central DNA flap. Cell (2000) 101(2):173-185.
83. Dvorin JD, Bell P, Maul GG, Yamashita M, Emerman M, Malim MH: Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J Virol (2002) 76(23):12087-12096.
84. Limon A, Nakajima N, Lu R, Ghory HZ, Engelman A: Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap. J Virol (2002) 76(23):12078-12086.
85. Whitwam T, Peretz M, Poeschla E: Identification of a central DNA flap in feline immunodeficiency virus. J Virol (2001) 75(19):9407-9414.
86. Leavitt AD, Robles G, Alesandro N, Varmus HE: Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrase viral DNA efficiently during infection. J Virol (1996) 70(2):721-728.
87. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R: Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol (1995) 69(5):2729-2736.
88. Engelman A: In vivo analysis of retroviral integrase structure and function. Adv Virus Res (1999) 52:411-426.
89. Naldini L, Blomer U, Gage FH, Trono D, Verma IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA (1996) 93(21):11382-11388.
90. Bloemer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH: Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol (1997) 71(9):6641-6649.
91. Elder JH, Lerner DL, Hasselkus-Light CS, Fontenot DJ, Hunter E, Luciw PA, Montelaro RC, Phillips TR: Distinct subsets of retroviruses encode dUTPase. J Virol (1992) 66(3):1791-1794.
92. May C, Rivella S, Callegari J, Heller G, Gaensler KM, Luzzatto L, Sadelain M: Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin. Nature (2000) 406(6791):82-86.
93. Pfeifer A, Ikawa M, Dayn Y, Verma IM: Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA (2002) 99(4):2140-2145.
94. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2003) 348(3):255-256.
95. Wu X, Li Y, Crise B, Burgess SM: Transcription start regions in the human genome are favored targets for MLV integration. Science (2003) 300(5626):1749-1751.
96. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F: HIV-1 integration in the human genome favors active genes and local hotspots. Cell (2002) 110(4):521-529.
97. Gage FH: Mammalian neural stem cells. Science (2000) 287(5457):1433-1438.
98. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP: Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science (1999) 285(5425):245-248.
99. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO: Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res (2003) 22(1):1-29.
100. Miyoshi H, Takahashi M, Gage FH, Verma IM: Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA (1997) 94(19):10319-10323.
101. Takahashi M, Miyoshi H, Verma IM, Gage FH: Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Virol (1999) 73(9):7812-7816.
102. Bainbridge JW, Stephens C, Parsley K, Demaison C, Halfyard A, Thrasher AJ, Ali RR: In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther (2001) 8(21):1665-1668.
103. Timmers AM, Nguyen T, Saban D, Grant MB: Viral vectors for efficient gene delivery to RPE cells. Invest Ophthalmol Vis Sci (2001) 42:S125.
104. Auricchio A, Kobinger G, Anand V, Hildinger M, O'Connor E, Maguire AM, Wilson JM, Bennett J: Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: The retina as a model. Hum Mol Genet (2001) 10(26):3075-3081.
105. Duisit G, Conrath H, Saleun S, Folliot S, Provost N, Cosset FL, Sandrin V, Moullier P, Rolling F: Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. Mol Ther (2002) 6(4):446-454.
106. Doi K, Hargitai J, Kong J, Tsang SH, Wheatley M, Chang S, Goff S, Gouras P: Lentiviral transduction of green fluorescent protein in retinal epithelium: Evidence of rejection. Vision Res (2002) 42(4):551-558.
107. Wang G, Sinn PL, Zabner J, McCray PB Jr: Gene transfer to airway epithelia using feline immunodeficiency virus-based lentivirus vectors. Methods Enzymol (2002) 346:500-514.
108. Follenzi A, Sabatino G, Lombardo A, Boccaccio C, Naldini L: Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther (2002) 13(2):243-260.
109. Pan D, Gunther R, Duan W, Wendell S, Kaemmerer W, Kafri T, Verma IM, Whitley CB: Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol Ther (2002) 6(1):19-29.
110. Peng KW, Pham L, Ye H, Zufferey R, Trono D, Cosset FL, Russell SJ: Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther (2001) 8(19):1456-1463.
111. Park F, Ohashi K, Chiu W, Naldini L, Kay MA: Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet (2000) 24(1):49-52.
112. Kobinger GP, Weiner DJ, Yu QC, Wilson JM: Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol (2001) 19(3):225-230.
113. Chan SY, Empig CJ, Welte FJ, Speck RF, Schmaljohn A, Kreisberg JF, Goldsmith MA: Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 106(1):117-126.
114. Fu S, Chen D, Mao X, Zhang N, Ding Y, Bromberg JS: Feline immunodeficiency virus-mediated viral interleukin-10 gene transfer prolongs non-vascularized cardiac allograft survival. Am J Transplant (2003) 3(5):552-561.
115. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P et al: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 288(5466):669-672.
116. O'Rourke JP, Newbound GC, Kohn DB, Olsen JC, Bunnell BA: Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors. J Virol (2002) 76(3)1510-1515.
117. Ikeda Y, Collins MK, Radcliffe PA, Mitrophanous KA, Takeuchi Y: Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Ther (2002) 9(14):932-938.
118. Pizzato M, Blair ED, Fling M, Kopf J, Tomassetti A, Weiss RA, Takeuchi Y: Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Ther (2001) 8(14):1088-1096.
119. Pizzato M, Marlow SA, Blair ED, Takeuchi Y: Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol (1999) 73(10):8599-8611.
120. Bieniasz PD, Cullen BR: Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol (2000) 74(21):9868-9877.
121. Towers G, Bock M, Martin S, Takeuchi Y, Stoye JP, Danos O: A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci USA (2000) 97(22):12295-12299.
122. Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, Bieniasz PD: Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA (2002) 99(18):11914-11919.
123. Besnier C, Takeuchi Y, Towers G: Restriction of lentivirus in monkeys. Proc Natl Acad Sci USA (2002) 99(18):11920-11925.
124. Munk C, Brandt SM, Lucero G, Landau NR: A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci USA (2002) 99(21):13843-13848.
125. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD, Towers GJ: Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J (2003) 22(3):385-394.
126. Shibata R, Sakai H, Kawamura M, Tokunaga K, Adachi A: Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol (1995) 76(11):2723-2730.
127. Hofmann W, Schubert D, LaBonte J, Munson L, Gibson S, Scammell J, Ferrigno P, Sodroski J: Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol (1999) 73(12):10020-10028.
128. Stoye JP: An intracellular block to primate lentivirus replication. Proc Natl Acad Sci USA (2002) 99(18):11549-11551.
129. Pincus T, Hartley JW, Rowe WP: A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med (1971) 133(6):1219-1233.
130. Best S, Le Tissier P, Towers G, Stoye JP: Positional cloning of the mouse retrovirus restriction gene Fv1. Nature (1996) 382(6594):826-829.
131. Stoye JP: Fv1, the mouse retrovirus resistance gene. Rev Sci Tech (1998) 17(1):269-277.
132. Goff SP: Operating under a Gag order: A block against incoming virus by the Fv1 gene. Cell (1996) 86(5):691-693.
133. Boone LR, Innes CL, Heitman CK: Abrogation of Fv1 restriction by genome-deficient virions produced by a retrovirus packaging cell line. J Virol (1990) 64(7):3376-3381.
134. Gao G, Guo X, Goff SP: Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science (2002) 297(5587):1703-1706.
135. Yap MW, Stoye JP: Intracellular localisation of Fv1. Virology (2003) 307(1):76-89.
136. Sheehy AM, Gaddis NC, Choi JD, Malim MH: Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature (2002) 418(6898):646-650.
137. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD et al: Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (2000) 290(5492):767-773.
138. Tarantal AF, Lee CI, Ekert JE, McDonald R, Kohn DB, Plopper CG, Case SS, Bunnell BA: Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): Lung-targeting approaches. Mol Ther (2001) 4(6):614-621.
139. Kordower JH, Bloch J, Ma SY, Chu Y, Palfi S, Roitberg BZ, Emborg M, Hantraye P, Deglon N, Aebischer P: Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol (1999) 160(1):1-16.
140. Horn PA, Morris JC, Bukovsky AA, Andrews RG, Naldini L, Kurre P, Kiem HP: Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons. Gene Ther (2002) 9(21):1464-1471.
141. Poeschla E, Gilbert J, Li X, Huang S, Ho A, Wong-Staal F: Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J Virol (1998) 72(8):6527-6536.
142. Schnell T, Foley P, Wirth M, Munch J, Uberla K: Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther (2000) 11(3):439-447.
143. Pandya S, Boris-Lawrie K, Leung NJ, Akkina R, Planelles V: Development of a Rev-independent, minimal simian immunodeficiency virus-derived vector system. Hum Gene Ther (2001) 12(7):847-857.
144. Negre D, Mangeot PE, Duisit G, Blanchard S, Vidalain PO, Leissner P, Winter AJ, Rabourdin-Combe C, Mehtali M, Moullier P, Darlix JL et al: Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther (2000) 7(19):1613-1623.